10X Genomics, Inc. et al v. Nanostring Technologies, Inc.
Case Number:
1:21-cv-00653
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 18, 2024
Biotech Co. NanoString Lands $393M Bid At Ch. 11 Auction
Scientific instrument maker Bruker Corp. is set to acquire insolvent biotechnology company NanoString for roughly $393 million in cash that would be used to repay creditors under the debtor's recently proposed Chapter 11 plan, a notice filed in Delaware's bankruptcy court shows.
-
January 18, 2024
NanoString Says Doubled Award Would Be 'Death Sentence'
Seattle biotech NanoString Technologies Inc. has told a Delaware court that if rival 10x Genomics' request to double a $31 million award in a jury's November finding of willful infringement is granted, it could bankrupt the company and cause harm to both patients and the general public.
-
December 21, 2023
Judge Asked To Double $31M Genetic Testing Verdict
California biotech startup 10X Genomics asked a federal court in Delaware Wednesday to double a $31 million jury verdict against a rival, which came down last month in a patent dispute surrounding a new way of analyzing genes.
-
November 17, 2023
Del. Jury Says NanoString Owes $31M In 10x Patent Spat
A Delaware federal jury on Friday determined that Seattle-based NanoString Technologies Inc. willfully infringed several gene technology patents exclusively licensed to 10x Genomics and awarded more than $31 million in damages, 10x Genomics announced.
-
September 07, 2023
Rival Gene Sequencing Cos. Must Face November Patent Trial
A Delaware federal judge refused Thursday to hand Seattle-based NanoString Technologies Inc. a win on certain gene technology patent infringement claims asserted by rival 10x Genomics, barring NanoString from arguing that the patent claims are too indefinite to be protected and sending the case to a November jury trial.
-
May 06, 2021
10x Launches Patent Suit Against NanoString
10x Genomics has launched a suit in Delaware federal court making patent infringement claims against NanoString Technologies Inc. over products relating to molecular profiling technology.